Similar articles

• Gender differences in clinical psychopharmacology.

  Clayton AH. Clayton AH. J Clin Psychiatry. 2005 Sep;66(9):1191. doi: 10.4088/jcp.v66n0916. J Clin Psychiatry. 2005. PMID: 16187779 No abstract available.
• [Psychopharmaceuticals as instruments for research].

  Vinar O. Vinar O. Cesk Psychiatr. 1988 Feb;84(1):28-35. Cesk Psychiatr. 1988. PMID: 2896551 Czech. No abstract available.
• Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology.

  Hyman SE. Hyman SE. Psychosomatics. 1988 Summer;29(3):254-63. doi: 10.1016/S0033-3182(88)72361-0. Psychosomatics. 1988. PMID: 2900534 Review. No abstract available.
• Managing interactions between cognitive enhancers and other psychotropics.

  Tang SW, Tang WH, Leonard BE. Tang SW, et al. Int Clin Psychopharmacol. 2017 Jul;32(4):175-183. doi: 10.1097/YIC.0000000000000172. Int Clin Psychopharmacol. 2017. PMID: 28234656 Review.
• [Dimensional approach to trans-nosographic study of psychotropic drugs].

  Jouvent R. Jouvent R. Encephale. 1995 Feb;21 Spec No 1:39-43. Encephale. 1995. PMID: 7729355 Review. French. No abstract available.